116 related articles for article (PubMed ID: 3491324)
1. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells.
Bonthron DT; Handin RI; Kaufman RJ; Wasley LC; Orr EC; Mitsock LM; Ewenstein B; Loscalzo J; Ginsburg D; Orkin SH
Nature; 1986 Nov 20-26; 324(6094):270-3. PubMed ID: 3491324
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
Turecek PL; Váradi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
[TBL] [Abstract][Full Text] [Related]
3. Processing and characterization of recombinant von Willebrand factor expressed in different cell types using a vaccinia virus vector.
Meulien P; Nishino M; Mazurier C; Dott K; Piétu G; Jorieux S; Pavirani A; Girma JP; Oufkir D; Courtney M
Thromb Haemost; 1992 Jan; 67(1):154-60. PubMed ID: 1615470
[TBL] [Abstract][Full Text] [Related]
4. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
7. Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage.
Journet AM; Saffaripour S; Wagner DD
Thromb Haemost; 1993 Dec; 70(6):1053-7. PubMed ID: 8165600
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
Lanke E; Kristoffersson AC; Philips M; Holmberg L; Lethagen S
Thromb Haemost; 2008 Aug; 100(2):211-6. PubMed ID: 18690339
[TBL] [Abstract][Full Text] [Related]
9. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
[TBL] [Abstract][Full Text] [Related]
10. [Biology of von Willebrand factor].
Girma JP
Nephrol Ther; 2006 Jan; 2 Suppl 2():S143-8. PubMed ID: 17373215
[TBL] [Abstract][Full Text] [Related]
11. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
[TBL] [Abstract][Full Text] [Related]
12. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers.
Wise RJ; Pittman DD; Handin RI; Kaufman RJ; Orkin SH
Cell; 1988 Jan; 52(2):229-36. PubMed ID: 3124962
[TBL] [Abstract][Full Text] [Related]
13. Reduction of von Willebrand factor by endothelial cells.
Xie L; Chesterman CN; Hogg PJ
Thromb Haemost; 2000 Sep; 84(3):506-13. PubMed ID: 11019979
[TBL] [Abstract][Full Text] [Related]
14. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation.
Ruggeri ZM
Best Pract Res Clin Haematol; 2001 Jun; 14(2):257-79. PubMed ID: 11686099
[TBL] [Abstract][Full Text] [Related]
15. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
Kashiwagi T; Matsushita T; Ito Y; Hirashima K; Sanda N; Fujimori Y; Yamada T; Okumura K; Takagi A; Murate T; Katsumi A; Takamatsu J; Yamamoto K; Naoe T; Kojima T
Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
[TBL] [Abstract][Full Text] [Related]
16. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor storage requires intact prosequence cleavage site.
Journet AM; Saffaripour S; Cramer EM; Tenza D; Wagner DD
Eur J Cell Biol; 1993 Feb; 60(1):31-41. PubMed ID: 8462598
[TBL] [Abstract][Full Text] [Related]
18. Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease.
Holmberg L; Karpman D; Isaksson C; Kristoffersson AC; Lethagen S; Schneppenheim R
Thromb Haemost; 1998 Apr; 79(4):718-22. PubMed ID: 9569179
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation.
Verweij CL; Hart M; Pannekoek H
J Biol Chem; 1988 Jun; 263(17):7921-4. PubMed ID: 3131331
[TBL] [Abstract][Full Text] [Related]
20. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C
Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
